Balchem Corporation

BCPC Basic Materials Specialty Chemicals

Balchem Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 8.75% from fiscal 2024.

Revenue
+8.63%
EPS
+17.7%
Free cash flow
+14.4%
Total debt
−16.7%

Quarter to September 2026, against a year earlier

179.33 3.25 −1.78%
Market cap
$5.7B
P/E
33.8×
Fwd P/E
31.0×
Dividend yield
0.54%
F-score
9/9
Altman Z
9.01
Beneish M
−2.45
Dividend safety
76/100

Insider Decisions last twelve months

Sold, $m 2.15
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell 2 — — — — — — — — — — —
Insider Ownership 0.30%

Capital & Financial Ratios $m

Size
Market Cap 5,710.00
Revenue ttm 1,108.98
Net income ttm 170.85
Free cash flow ttm 178.27
Net debt Q 81.06
Valuation
P/E 33.77
Forward P/E 31.00
Price / sales 5.13
Forward P/S Powerpack
Price / FCF 0.00
Price / book 4.28
Financial health
Current ratio Q 2.47 (at or above 1.5: strong)
Debt / equity Q 0.11 (at or below 0.5: strong)
Interest coverage Q 32.28
Growth
Revenue growth Q +8.63% (above 0%: growing)
Operating income growth Q +14.40% (above 0%: growing)
EPS, this year +15.37% (at or above 15%: strong)
EPS, next year A +4.32%
Revenue, next year A +9.14%
EPS, past 5 yrs +12.81%
EPS, next 5 yrs A +7.49%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/E against its own 10 years 15.58%
10-year low 10-year high
P/S against its own 10 years 66.89%
10-year low 10-year high
P/B against its own 10 years 37.99%
10-year low 10-year high
EV/Sales against its own 10 years 55.59%
10-year low 10-year high

Dividends

Yield
0.54%
Annual rate
0.96
Payout ratio
18.1%
Growth, 2017–25
+10.9%/yr
  1. 0.42 ’17
  2. 0.47 ’18 +12
  3. 0.52 ’19 +11
  4. 0.58 ’20 +12
  5. 0.64 ’21 +10
  6. 0.71 ’22 +11
  7. 1.19 ’23 +67
  8. 0.87 ’24 −27
  9. 0.96 ’25 +10
paid change on the year, % Powerpack

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 64 50 75 66
Receivables 125 120 144 146
Inventory 110 131 131 177
Other 7 6 6 6
314 314 366 405
2023 2024 2025 Q'26
Payables 56 55 60 72
ST’ Debt — — — —
Other — — — —
148 158 176 164

Compound Annual Growth %

10y 5y 3y
Sales 6.50% 8.07% 3.25%
Cash Flow 7.63% 7.55% 16.06%
Earnings 10.00% 12.84% 13.69%
Book Value 10.49% 8.71% 10.25%

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 1.25 1.39 1.46 — —
’25 1.13 1.17 1.24 1.21 4.75
’24 0.89 0.98 1.03 1.03 3.93
’23 0.70 0.93 0.90 0.82 3.35
’22 0.89 0.92 0.78 0.66 3.25
’21 0.72 0.70 0.77 0.76 2.94
’20 0.61 0.65 0.66 0.68 2.60
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 271 284 291 — —
’25 251 255 268 264 1,037
’24 240 234 240 240 954
’23 233 231 230 229 922
’22 229 237 244 233 942
’21 186 202 198 213 799
’20 174 173 175 181 704
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 40 47 70 — —
’25 36 47 66 67 217
’24 33 45 51 52 182
’23 35 35 47 67 184
’22 7 48 42 42 139
’21 41 36 40 44 161
’20 23 45 35 48 150
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 34 36 57 — —
’25 31 41 50 51 173
’24 27 38 42 40 147
’23 25 29 38 56 148
’22 (3) (258) 27 28 89
’21 34 28 31 30 123
’20 17 37 28 35 117
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.6
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 553 595 644 644 704 799 942 922 954 1,037 1,109 +7.2% 1,132 1,199 1,264 +6.8%
Gross margin, % 32.69 31.78 31.73 32.84 31.82 30.43 29.76 32.75 35.25 35.74 36.46 +3.0 pt
EBT 83 88 99 96 106 125 134 137 166 199 220 +10.2%
EBT margin, % 14.99 14.88 15.38 14.99 15.12 15.67 14.19 14.88 17.45 19.19 19.87 +4.2 pt
Net income 56 90 79 80 85 96 105 109 128 155 171 +12.0%
Per share, $
Per share, $ Revenue 17.55 18.68 20.06 20.03 21.87 24.80 29.43 28.73 29.50 32.15 34.99 +7.0%
Earnings 1.75 2.79 2.42 2.45 2.60 2.94 3.25 3.35 3.93 4.75 5.31 +11.7%
Cash flow 3.41 3.47 3.70 3.87 4.68 4.98 4.33 5.72 5.63 6.71 7.06 +7.8%
Capex (0.76) (0.88) (0.61) (0.88) (1.05) (1.15) (1.55) (1.12) (1.09) (1.34) (1.44) +6.5%
Free cash flow 2.65 2.59 3.08 2.99 3.63 3.83 2.77 4.60 4.54 5.37 5.62 +8.2%
Book value 16.53 19.38 21.55 23.14 25.74 27.22 29.30 32.83 35.57 38.97 41.86 +10.0%
Shares, m 32 32 32 32 32 32 32 32 32 32 32 +0.3%
Valuation, ×
Valuation, × P/E 47.58 29.23 32.24 41.31 44.32 57.15 37.47 43.64 41.48 32.29 33.77 40.7
P/S 4.74 4.36 3.91 5.07 5.27 6.80 4.14 5.09 5.53 4.77 5.13 5.0
P/B 5.04 4.21 3.64 4.39 4.48 6.19 4.16 4.45 4.58 3.94 4.28 4.5
EV/Sales 5.19 4.67 4.13 5.42 5.45 6.87 4.60 5.41 5.73 4.91 5.23 5.2
EV/FCF 34.36 33.78 26.77 36.35 32.84 44.40 (21.00) (33.82) (36.77) (41.55) (49.27) 7.5
Cash, $m
Cash, $m Operating cash flow 108 111 119 124 150 161 139 184 182 217 224 +8.1%
Capex (24) (28) (20) (28) (34) (37) (50) (36) (35) (43) (46) +6.8%
Free cash flow 84 83 99 96 117 123 89 148 147 173 178 +8.4%
Balance, $m
Balance, $m Working capital 87 91 144 163 172 178 196 166 156 189 241 +9.0%
Net debt 249 184 109 191 92 21 403 264 162 112 81 (8.4%)
Shareholders’ equity 521 617 692 744 828 877 938 1,054 1,150 1,257 1,327 +10.3%
Returns, %
Returns, % ROA 6.12 9.42 8.08 7.46 7.29 8.13 7.46 6.74 8.10 9.49 10.16 +3.4 pt
ROIC 7.38 7.56 8.36 6.86 7.55 8.87 6.77 7.55 8.72 9.55 10.19 +2.2 pt
ROE 11.37 15.83 12.01 11.10 10.77 11.27 11.61 10.90 11.66 12.86 13.02 +1.5 pt
People
People Employees 1,060 1,165 1,135 1,424 1,342 1,317 1,340 1,302 1,361 1,352 — +2.7%
Revenue/emp, $m 0.52 0.51 0.57 0.45 0.52 0.61 0.70 0.71 0.70 0.77 — +4.4%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 2 Nov 2026

Balchem Corporation vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
SQM Sociedad Quimica y Minera S.A. $8.1B 10.6× 7.4× +138.12% (above 0%: growing) +381.25% (above 0%: growing) −63.75% (below 0%: shrinking) 51.05% 48.62% Compare
AXTA Axalta Coating Systems Ltd. $7.8B 23.3× 18.8× +1.79% (above 0%: growing) −12.96% (below 0%: shrinking) +2.30% (above 0%: growing) 33.10% 12.59% Compare
EMN Eastman Chemical Company $7.5B 12.0× 11.5× +8.31% (above 0%: growing) +266.44% (above 0%: growing) −26.42% (below 0%: shrinking) 22.31% 12.79% Compare
ESI Element Solutions Inc. $7.5B 36.4× 30.7× +51.70% (above 0%: growing) +68.75% (above 0%: growing) +53.88% (above 0%: growing) 34.40% 11.44% Compare
NEU NewMarket Corporation $6.4B 14.0× — (loss-making) +3.79% (above 0%: growing) +26.52% (above 0%: growing) −73.94% (below 0%: shrinking) 31.03% 19.95% Compare
BCPC Balchem Corporation $5.7B 33.8× 31.0× +8.63% (above 0%: growing) +17.74% (above 0%: growing) +14.42% (above 0%: growing) 36.37% 21.48%
SXT Sensient Technologies Corporation $5.1B 30.0× 28.0× +10.61% (above 0%: growing) +31.03% (above 0%: growing) −90.87% (below 0%: shrinking) 36.19% 15.89% Compare
PRM Perimeter Solutions, SA $4.6B 102× 27.1× +23.59% (above 0%: growing) n/m −22.31% (below 0%: shrinking) 61.14% 106.82% Compare
AVNT Avient Corporation $4.2B 23.1× 17.6× +10.50% (above 0%: growing) +31.78% (above 0%: growing) +101.69% (above 0%: growing) 30.50% 9.27% Compare
Median of peers $6.9B 23.2× 18.8× +10.56% +31.78% −24.36% 33.75% 14.34%

All 61 Specialty Chemicals stocks →

Pay and ownership Proxy statement filed 27 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 7.89m 4.92m 136.68
2024 6.87m 10.37m 144.37
2023 5.89m 10.94m 131.07
2022 11.95m 7.98m 107.02
2021 5.76m 12.20m 146.90

Ownership

Directors and executive officers, together 1.65%
BlackRock, Inc. 14.59%
The Vanguard Group, Inc. 11.80%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Balchem Corporation (BCPC) Latest News

25 Oct

Impact 4 · · Simply Wall St.

24 Oct

23 Oct

Impact 4 · · The Motley Fool
Impact 4 · · The Motley Fool transcript

25 Sep

6 May

Impact 3 · · Insider Monkey

30 Apr

Impact 4 · · The Motley Fool transcript

BCPC metrics, ten years each

stockrow.com/BCPC · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com